Cytori Therapeutics Inc


Stock Update (NASDAQ:CYTX): Cytori Therapeutics Inc ATHENA Trial Results Support Symptomatic Benefit From Cytori Cell Therapy

Cytori Therapeutics Inc (NASDAQ:CYTX) announced the presentation of six and twelve month data from the ATHENA Trials at the annual meeting of The Society …

Stock Update (NASDAQ:CYTX): Cytori Therapeutics Inc Reports Preliminary Preclinical Data Supporting Use of Cytori Cell Therapy for Both the Prevention and Treatment of Hypertrophic Scars

Cytori Therapeutics Inc (NASDAQ:CYTX) presented preclinical data at the Annual Meeting of the American Burn Association (ABA) in Las Vegas showing the potential …

Maxim’s Biotech Insights: Cytori Therapeutics Inc (CYTX), StemCells Inc (STEM)

Recent developments in biotech stocks Cytori Therapeutics Inc (NASDAQ:CYTX) and StemCells Inc (NASDAQ:STEM) attract analysts’ attention as pipeline treatments inch toward the end of their final testing …

Healthcare Analysts Bullish on Allergan plc Ordinary Shares (AGN) and Cytori Therapeutics Inc (CYTX) Following Earnings and Data Release

Healthcare analysts from Mizuho and Maxim weigh in on pharma giant Allergan plc Ordinary Shares (NYSE:AGN) and cell therapy firm Cytori Therapeutics Inc (NASDAQ:CYTX), following …

Stock Update (NASDAQ:CYTX): Cytori Therapeutics Inc Reports Interim Data on U.S. Phase II Osteoarthritis Trial

Cytori Therapeutics Inc (NASDAQ:CYTX) announced the top-line data as part of the pre-specified partial unblinding of 24 week follow up data from the …

Company Update (NASDAQ:CYTX): Cytori Therapeutics Inc Update on Its U.S. Phase III Scleroderma Trial

Cytori Therapeutics Inc (NASDAQ:CYTX) announced that its U.S.

Company Update (NASDAQ:CYTX): Cytori Therapeutics Inc Partner Kerastem Expands US Phase II Trial for Early Stage Hair Loss

Cytori Therapeutics Inc (NASDAQ:CYTX) announced today that its licensee Kerastem Technologies, LLC, has expanded STYLE, its US phase II clinical trial investigating early …

Company Update (NASDAQ:CYTX): Cytori Therapeutics Inc Initiates Enrollment of Phase II Clinical Trial in Crohn’s Disease

Cytori Therapeutics Inc (NASDAQ:CYTX) announced enrollment of the first two patients in an investigator-initiated clinical trial of Cytori Cell Therapy™ for the treatment of …

Stock Update (NASDAQ:CYTX): Cytori Therapeutics Inc Enters Agreement with Idis to Launch Managed Access Program in EMEA

Cytori Therapeutics Inc (NASDAQ:CYTX) announced today that it has entered into an agreement with Idis Managed Access, part of the Clinigen Group plc, …

Analysts Weigh In on Two Falling Biotechs: Cytori Therapeutics Inc (CYTX), Osiris Therapeutics, Inc. (OSIR)

Analysts are weighing in on the biopharmaceutical companies Cytori Therapeutics Inc (NASDAQ:CYTX) and Osiris Therapeutics, Inc. (NASDAQ:OSIR), as shares of both companies fell …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts